3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Retinoblastoma
1
Retinal Neoplasms
1
Neoplasms
1
Keratosis, Actinic
1
Eye Neoplasms
1
Interventions
Carboplatin
12
Etoposide
10
Vincristine
9
Filgrastim
7
Melphalan
5
Cyclophosphamide
5
Topotecan
4
Thiotepa
4
Cryotherapy
3
Temozolomide
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Mesna
2
Granulocyte Colony-Stimulating Factor
2
Drug Therapy
2
Doxorubicin
2
Cisplatin
2
trioctyl phosphine oxide
1
pegfilgrastim
1
cixutumumab
1
becatecarin
1
abemaciclib
1
Specimen Handling
1
Ranibizumab
1
Proton Therapy
1
Platinum Compounds
1
Observation
1
Microscopy, Acoustic
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Retinoblastoma
×
Lasers
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled